SAB Share Price

SAB Share Price

NASDAQ: SABS | Micro Cap | Healthcare
$2.91
-$0.29 (-9.06%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

SAB Stock Performance

Open
$3.17
Prev. Close
$3.20
Circuit Range
N/A
Day Range
$2.54 - $3.17
Year Range
$2.44 - $5.12
Volume
3,53,345
Average Traded
$2.83

SAB Share Price Today

As of 20 November 2026, SAB Biotherapeutics, Inc.'s share price is $2.91. The stock opened at $3.17, compared to its previous close of $3.20. During today's trading session, SAB Biotherapeutics, Inc.'s share price traded between $2.54 and $3.17, with an average price of $2.85. Over the past 52 weeks, the stock has recorded a high of $5.12 and a low of $2.44. In terms of performance, SAB Biotherapeutics, Inc.'s share price has declined by 19.05% over the last six months and is down 26.79% on a year-on-year basis.

SAB Share Price Chart

Line chart of the SAB price trend over the selected period. The price fell overall, ranging from 2.98 to 3.32, ending at 3.19.
$2.54$3.17
L
Show Current Price
H

SAB Stock Fundamentals & Key Indicators

Market Cap
$56.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.74
Revenue (TTM)
$0.00
Return On Equity (TTM)
-31.53%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-682.46%

SAB Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.85-$18.87-$22.49-$22.30
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-562.11%-19.18%0.84%

SAB Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$23.90$2.24$1.32$0.00
Net Profit-$18.74-$42.19-$34.11$4.26
Net Profit Margin-78.41%-1883.48%-2584.09%N/A
Income ChangeN/A-125.13%19.15%112.49%

SAB Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets71.7620.425.0328.81
Current Assets101.0523.7958.9122.1
Total Assets172.8144.283.9450.9
Non Current Liabilities10.6310.2515.834.85
Current Liabilities10.687.9810.8114.99
Total Liabilities21.3218.2326.6419.85
Shareholders' Equity151.525.9757.331.06

SAB Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-44.78-34.29-25.12-23.46
Investing-121.71-11.96-0.15-2.09
Financing168.3-1.1766.771.05

Corporate Actions

Split
Ex-date: 05 Jan 2024

About SAB

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

SAB Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.33
$2.90
-13.02%
Oct 2026
$3.13
$3.34
+5.20%
Sep 2026
$3.70
$3.17
-19.01%
Aug 2026
$3.59
$3.92
+10.11%
Jul 2026
$3.90
$3.56
-8.72%
Jun 2026
$3.68
$3.90
+8.48%
May 2026
$3.73
$3.60
-3.62%
Apr 2026
$3.90
$3.73
-2.86%
Mar 2026
$3.98
$3.84
-6.20%
Feb 2026
$4.44
$4.09
-6.53%
Jan 2026
$3.77
$4.38
+17.43%
Dec 2025
$3.95
$3.73
-6.16%

SAB Share Price FAQs